Mefloquine one. Plasma concentrations of the (–)-enantiomer are significantly higher than those for the (+)-enantiomer, and the pharmacokinetics between the two enantiomers are significantly different. The (+)-enantiomer has a shorter half-life than the (–)-enantiomer. According to some research, the (+)-enantiomer is more effective in treating malaria, and the (–)-enantiomer specifically binds to adenosine receptors in the central nervous system, which may explain some of its psychotropic effects. Mefloquine was formulated at Walter Reed Army Institute of Research (WRAIR) in the 1970s shortly after the end of the Vietnam war. Mefloquine was number 142,490 of a total of 250,000 antimalarial compounds screened
Fools Gold/What the World Is Waiting For Fools Gold/What the World Is Waiting For "Fools Gold" and "What the World Is Waiting For" are two songs by British rock band the Stone Roses. They were released together as a double A-side single on 13 November 1989 through Silvertone Records. "Fools Gold" would go on to appear on certain non-UK versions of their self-titled debut studio album (1989). "Fools Gold" became the band's biggest commercial hit at the time. It was their first single to reach the top ten of the UK Singles Chart and stayed in the top-75 for fourteen weeks, peaking at number eight. "Fools Gold"